Clonidine Hydrochloride Tablet, Extended Release
Product Images NDC 60687-462
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Clonidine Hydrochloride (NDC 60687-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 Mean Clonidine Concentration-time Profiles After Single Dose Administration (Figure 1)
Figure 2: Kaplan-meier Estimation Of Cumulative Proportion Of Patients With Treatment Failure (study 3) (Figure 2)
This appears to be a graph displaying the proportion of patients with treatment failure over time, comparing a censored treatment with a placebo treatment. The graph shows the number of days from randomization to treatment failure, ranging from 0 to 220. The text seems to reference a drug called Chnidn Hyrochlorde ExandadAcase, which may be a misspelling.*
Structural Formula (Clonidine)
Image 01
Clonidine Hydrochloride Extended Release Tablets are prescription medicine in the form of 30 tablets used for treating high blood pressure conditions. Each tablet contains 0.1 mg Cloridine, Hycrochioride, USP equivalent to 0,087 mg Clonidine. Tablets must be swallowed whole and never crushed, cut, or chewed. These tablets are for use only by prescription and require appropriate dosage as per package insert for complete prescribing information. The product is distributed by American Hodih Packaging, Columbus, Ohio 43517.*
Image 02
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.